HEXO Corp (HEXO) Q2 2023 Earnings Call Transcript
HEXO Corp (NYSE: HEXO) Q2 2023 earnings call dated Mar. 17, 2023 Corporate Participants: Charlie Bowman — President and Chief Executive Officer...
Health Care
Cipher Pharmaceuticals Inc (CPH) Q4 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc (TSE: CPH) Q4 2022 earnings call dated Mar. 17, 2023 Corporate Participants: Craig Mull — Interim Chief Executive Officer...
BioLife Solutions Inc (BLFS) Q4 2022 Earnings Call Transcript
BioLife Solutions Inc (NASDAQ: BLFS) Q4 2022 earnings call dated Mar. 16, 2023 Corporate Participants: Troy Wichterman — Chief Financial Officer Michael...
Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with...
ANI Pharmaceuticals Inc (ANIP) Q4 2022 Earnings Call Transcript
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente — Investor Relations Nikhil Lalwani — President and...
Ocean Biomedical provides positive research data on anti-tumor pathway; stock climbs
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple...
Cara Therapeutics Inc (CARA) Q4 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner — President and Chief Executive Officer...
Patterson Companies Inc (PDCO) Q3 2023 Earnings Call Transcript
Patterson Companies Inc (NASDAQ: PDCO) Q3 2023 earnings call dated Mar. 02, 2023 Corporate Participants: John Wright — Vice President, Investor Relations...
Jazz Pharmaceuticals PLC (JAZZ) Q4 2022 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox — Executive Director, Investor Relations Bruce...
ImmunoGen Inc (IMGN) Q4 2022 Earnings Call Transcript
ImmunoGen Inc (NASDAQ:IMGN) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Anabel Chan — Head of Investor Relations Mark Enyedy — President...
Agilent (A) Q1 2023 earnings rise on higher revenues
Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa...
Corcept Therapeutics Incorporated (CORT) Q4 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari — Chief Financial Officer Charles Robb — Chief...
Novavax Inc (NVAX) Q4 2022 Earnings Call Transcript
Novavax Inc (NASDAQ:NVAX) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Erika Schultz — Senior Director of Investor Relations John...
Agilent Technologies Inc (A) Q1 2023 Earnings Call Transcript
Agilent Technologies Inc (NYSE:A) Q1 2023 Earnings Call dated Feb. 28, 2023. Corporate Participants: Parmeet Ahuja — Investor Relations Mike McMullen — President and...
PetIQ Inc (PETQ) Q4 2022 Earnings Call Transcript
PetIQ Inc (NASDAQ:PETQ) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Katie Turner — Investor Relations McCord Christensen — Chief Executive Officer...
Ocean Biomedical co-founder Jake Kurtis gets new patent for novel malaria vaccine target
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his...
BioMarin Pharmaceutical Inc (BMRN) Q4 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Traci McCarty — Group Vice President of Investor...
FibroGen Inc (FGEN) Q4 2022 Earnings Call Transcript
FibroGen Inc (NASDAQ:FGEN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Michael Tung — Vice President, Corporate Strategy and Investor...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the...
Infographic: Ocean Biomedical Inc. (OCEA) quarter ended September 30, 2022
Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here’s a look at...
Infographic: Ocean Biomedical Inc. (OCEA) quarter ended June 30, 2022
Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here are the company’s...